Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
about
The ITP syndrome: pathogenic and clinical diversity.Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.Chronic lymphocytic leukemia and autoimmunity: a systematic review.Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.Autoimmune cytopenias in chronic lymphocytic leukemia.Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?Contemporary treatment of immune thrombocytopenia.Autoimmune cytopenias in chronic lymphocytic leukemia, facts and mythsPhase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.Autoimmune thrombocytopenia: a complication of fludarabine therapy in the treatment of Waldenstrom's macroglobulinemiaEvans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy.Clinical and serological autoimmune complications in chronic lymphocytic leukemia.Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.Management of chronic lymphocytic leukemia.VDJSeq-Solver: in silico V(D)J recombination detection tool.Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status.Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination?IGHV gene rearrangements as outcome predictors for CLL patients: experience of Ukrainian group.Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study.Splenectomy for Immune Thrombocytopenia: Down but not out.
P2860
Q33384235-92CB5B17-27FB-4EB9-9E21-B02FE29663BBQ33386533-BCFEFFB5-2686-4BDF-B7D9-E777E236AF5AQ33390656-76554C26-C78F-4228-B338-876F1E1354B7Q33393126-EE206F45-D165-41BB-B139-7D4C7388C8B0Q33393696-0674ADAE-F9CF-49F1-91A0-D18913970B81Q33395141-EA134B1B-7C28-4457-B9F6-FA4D397F3320Q33405017-5DFC0D36-CE04-4114-9E7A-C879F8380E62Q33406598-5BBA36A9-A227-46F8-999D-BA83860EC823Q33407700-7AAB232F-E37D-43A5-8C5E-6BF571EBED83Q33407866-AC5F3A4B-96B5-4B20-B5CD-5397F871CC4AQ33409149-2A807657-0E28-43C9-ABD6-C121F41EA5FDQ33410390-735B7698-563D-46C0-8F0C-3EE717B1CB28Q33410653-36FA1F22-343C-4CBB-B464-41BA9E5B0318Q33412266-80E14E7C-EF4E-427A-9BB0-A69CB1ABBEC0Q33414468-544D9721-2D9C-4273-BDF3-02B7CA438A81Q33420255-0270BFEC-13CE-42A6-BDFC-CE84C6DCDAB6Q33430911-44A1014E-0F4B-4C93-AF18-06C1AAD71720Q33441590-BBC4BEE9-87E8-4748-894A-052B74768F5EQ33441658-CE573E79-715F-40FE-B6C8-9D09D8280075Q33442354-5BEC9716-2E6D-44AC-8770-59251E6C28C5Q33695912-DF493D36-69D1-4802-A55F-E65BA20F90F5Q35583972-0477D048-44A0-42D9-BEA7-13BCA0EBAF7CQ42739945-575330B2-3342-455C-A406-18043ECBC867Q43225253-F9062BC4-B776-41E9-A162-8D1F93B2499AQ44563802-53177AB5-48B2-4EFD-B43E-7A8C53C696D2Q47253706-59EBCAC4-0A10-4A6F-BE0A-9E3D4383626DQ47754303-B11D966F-80EA-4E00-B796-63D0C42A7A0F
P2860
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@ast
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@en
type
label
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@ast
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@en
prefLabel
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@ast
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@en
P2093
P921
P1433
P1476
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia.
@en
P2093
Achille Ambrosetti
Carlo Visco
Domenico Madeo
Francesco Rodeghiero
Giovanni Pizzolo
Ilaria Giaretta
Marco Ruggeri
Maria Laura Evangelista
Roberta Zanotti
Roberto Stasi
P304
P356
10.1182/BLOOD-2007-09-111492
P407
P577
2007-11-06T00:00:00Z